ES516797A0 - Un procedimiento para preparar un anticuerpo monoclonal para un antigeno asociado a un tumor. - Google Patents

Un procedimiento para preparar un anticuerpo monoclonal para un antigeno asociado a un tumor.

Info

Publication number
ES516797A0
ES516797A0 ES516797A ES516797A ES516797A0 ES 516797 A0 ES516797 A0 ES 516797A0 ES 516797 A ES516797 A ES 516797A ES 516797 A ES516797 A ES 516797A ES 516797 A0 ES516797 A0 ES 516797A0
Authority
ES
Spain
Prior art keywords
tumor
preparing
procedure
monoclonal antibody
antigen associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES516797A
Other languages
English (en)
Spanish (es)
Other versions
ES8404857A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hybritech Inc
University of California
Original Assignee
Hybritech Inc
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc, University of California filed Critical Hybritech Inc
Publication of ES516797A0 publication Critical patent/ES516797A0/es
Publication of ES8404857A1 publication Critical patent/ES8404857A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1066—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES516797A 1981-10-27 1982-10-25 Un procedimiento para preparar un anticuerpo monoclonal para un antigeno asociado a un tumor. Expired ES8404857A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31528681A 1981-10-27 1981-10-27

Publications (2)

Publication Number Publication Date
ES516797A0 true ES516797A0 (es) 1984-05-16
ES8404857A1 ES8404857A1 (es) 1984-05-16

Family

ID=23223718

Family Applications (2)

Application Number Title Priority Date Filing Date
ES516797A Expired ES8404857A1 (es) 1981-10-27 1982-10-25 Un procedimiento para preparar un anticuerpo monoclonal para un antigeno asociado a un tumor.
ES529310A Granted ES529310A0 (es) 1981-10-27 1984-01-31 Un procedimiento para preparar un producto que contiene un anticuerpo monoclonal y un radionuclido metalico

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES529310A Granted ES529310A0 (es) 1981-10-27 1984-01-31 Un procedimiento para preparar un producto que contiene un anticuerpo monoclonal y un radionuclido metalico

Country Status (18)

Country Link
JP (1) JPS58135820A (fi)
AT (1) AT392004B (fi)
BE (1) BE894829A (fi)
CA (1) CA1202892A (fi)
CH (1) CH653040A5 (fi)
DE (1) DE3239410A1 (fi)
DK (1) DK164682C (fi)
ES (2) ES8404857A1 (fi)
FI (1) FI82379C (fi)
FR (1) FR2515046B1 (fi)
GB (1) GB2109407B (fi)
IL (1) IL67068A0 (fi)
IT (1) IT1153857B (fi)
LU (1) LU84441A1 (fi)
NL (1) NL8204108A (fi)
NO (1) NO169947C (fi)
SE (1) SE8206073L (fi)
ZA (1) ZA827806B (fi)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
CA1225930A (en) * 1982-06-07 1987-08-25 Otto A. Gansow Metal chelate conjugated monoclonal antibodies
US4741900A (en) * 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
SE8401946L (sv) * 1983-04-08 1984-11-13 Kureha Chemical Ind Co Ltd Antikropp mot human prostatacancer
GB2140030A (en) * 1983-04-08 1984-11-21 Kureha Chemical Ind Co Ltd Monoclonal antibody to human urinary bladder cancer
JPS59199636A (ja) * 1983-04-26 1984-11-12 Nippon Mejifuijitsukusu Kk 放射性診断剤
US4677058A (en) * 1983-05-19 1987-06-30 Karl Tryggvason Detecting malignant cells with monoclonal antibodies specific to type IV collagenase enzyme
US4732864A (en) * 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
JPS60201260A (ja) * 1984-03-27 1985-10-11 Yamasa Shoyu Co Ltd 心疾患診断薬
JP2507982B2 (ja) * 1984-04-10 1996-06-19 武田薬品工業株式会社 ヒト癌胎児性抗原反応性モノクロ―ナル抗体の製造法
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
CA1260827A (en) * 1984-08-31 1989-09-26 Richard C. Siegel Antibody-metal ion complexes
US4837003A (en) * 1984-09-13 1989-06-06 Mallinckrodt, Inc. Radiolabeled antibody fragments
US4659839A (en) * 1984-10-10 1987-04-21 Mallinckrodt, Inc. Coupling agents for radiolabeled antibody fragments
US5242679A (en) * 1985-01-14 1993-09-07 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4897255A (en) * 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4986256A (en) * 1985-02-28 1991-01-22 The United States Of America As Represented By The Department Of Health And Human Services Use of paramagnetic metalloporphyrins as contrast agents for tumors in MRI imaging
US4824986A (en) * 1985-04-26 1989-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Metal chelate protein conjugate
US4830847A (en) * 1985-06-28 1989-05-16 The Procter & Gamble Company Diphosphonate-derivatized macromolecules
US4732974A (en) * 1986-03-05 1988-03-22 Mallinckrodt, Inc. Metal ion labeling of carrier molecules
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
US4861869A (en) * 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
US5082930A (en) * 1986-05-29 1992-01-21 Mallinckrodt Medical, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
US4925804A (en) * 1986-06-17 1990-05-15 Baxter International Inc. Interligand metal transfer assay
US4831175A (en) * 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US5246692A (en) * 1986-09-05 1993-09-21 The United States Of America As Represented By The Secretary Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
FR2604092B1 (fr) * 1986-09-19 1990-04-13 Immunotech Sa Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo
CA1340014C (en) * 1986-10-27 1998-08-25 Bryan Michael Longenecker Carcinoma-marking monoclonal antibodies elicited with synthetic asialo-gmi antigen
US5057302A (en) * 1987-02-13 1991-10-15 Abbott Laboratories Bifunctional chelating agents
US5227474A (en) * 1987-02-13 1993-07-13 Abbott Laboratories Bifunctional chelating agents
DE3710730A1 (de) * 1987-03-31 1988-10-20 Schering Ag Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
US5177192A (en) * 1987-04-02 1993-01-05 Centocor, Incorporated Method for labeling antibodies with a metal ion
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US4838274A (en) * 1987-09-18 1989-06-13 Air Products And Chemicals, Inc. Perfluoro-crown ethers in fluorine magnetic resonance imaging
US5217704A (en) * 1987-11-06 1993-06-08 Abbott Laboratories Methods and materials for the preparation of metal labelled antibody solutions
US5648471A (en) * 1987-12-03 1997-07-15 Centocor, Inc. One vial method for labeling antibodies with Technetium-99m
US4867962A (en) * 1988-02-26 1989-09-19 Neorx Corporation Functionally specific antibodies
US5075099A (en) * 1988-05-31 1991-12-24 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US4988496A (en) * 1988-05-31 1991-01-29 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5218128A (en) * 1988-06-15 1993-06-08 Centocor, Inc. Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
US5688488A (en) * 1989-04-03 1997-11-18 Purdue Research Foundation Composition and method for tumor imaging
US5792444A (en) * 1989-05-09 1998-08-11 The General Hospital Corporation Labeled chemotactic peptides to image focal sites of infection or inflammation
PT590766E (pt) * 1992-07-31 2000-07-31 Australian Nuclear Science Tec Complexos metalicos de hidroxiarilo contendo agentes quelantes de acido aminocarboxilico
US5807535A (en) * 1992-07-31 1998-09-15 Australian Nuclear Science & Technology Organisation Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
US6558669B1 (en) 1996-08-28 2003-05-06 Immunomedics, Inc. Stable radioiodine conjugates and methods for their synthesis
US7521531B2 (en) 1996-08-28 2009-04-21 Immunomedics, Inc. Methods for the purification of stable radioiodine conjugates
US6663866B1 (en) 1996-08-28 2003-12-16 Immunomedics, Inc. Stable radioiodine conjugates and methods for their synthesis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323546A (en) * 1978-05-22 1982-04-06 Nuc Med Inc. Method and composition for cancer detection in humans
US4272503A (en) * 1978-05-25 1981-06-09 New England Nuclear Corporation Reductant composition for technetium-99m and method for making technetium-99m labelled ligands
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
AU556548B2 (en) * 1980-03-03 1986-11-06 Milton David Goldenberg Tumor localization and therapy with labeled antibodies and antibody fragments specific to tumor-associated markers

Also Published As

Publication number Publication date
SE8206073D0 (sv) 1982-10-26
FI82379B (fi) 1990-11-30
GB2109407B (en) 1985-12-18
ES8505482A1 (es) 1985-05-16
JPH0564130B2 (fi) 1993-09-14
FR2515046B1 (fr) 1985-11-29
SE8206073L (sv) 1983-04-28
DK164682C (da) 1992-12-21
CA1202892A (en) 1986-04-08
IL67068A0 (en) 1983-02-23
NO169947C (no) 1992-08-26
JPS58135820A (ja) 1983-08-12
LU84441A1 (fr) 1983-06-13
IT8223932A0 (it) 1982-10-26
GB2109407A (en) 1983-06-02
FI82379C (fi) 1991-03-11
IT1153857B (it) 1987-01-21
DK474182A (da) 1983-04-28
ATA391682A (de) 1990-07-15
FI823633A0 (fi) 1982-10-25
BE894829A (fr) 1983-02-14
DK164682B (da) 1992-08-03
ES529310A0 (es) 1985-05-16
NO823530L (no) 1983-04-28
NL8204108A (nl) 1983-05-16
ZA827806B (en) 1983-08-31
FI823633L (fi) 1983-04-28
DE3239410C2 (fi) 1991-12-19
ES8404857A1 (es) 1984-05-16
FR2515046A1 (fr) 1983-04-29
CH653040A5 (de) 1985-12-13
NO169947B (no) 1992-05-18
DE3239410A1 (de) 1983-05-19
AT392004B (de) 1991-01-10

Similar Documents

Publication Publication Date Title
ES516797A0 (es) Un procedimiento para preparar un anticuerpo monoclonal para un antigeno asociado a un tumor.
BR8507031A (pt) Anticorpo monoclonal para um antigeno associado com tumor de carcinoma
DE3382283D1 (de) Monoklonale antikoerper spezifisch gegen das karzinoembryonische antigen.
ES495165A0 (es) Un anticuerpo monoclonal
ES551497A0 (es) Procedimiento de obtencion de un anticuerpo monoclonal reactivo con antigenos de esporozoitos de eimeria spp.
DE3885355D1 (de) Monoklonale Antikörper.
ES551494A0 (es) Procedimiento de obtencion de un anticuerpo monoclonal reactivos con antigenos de esporozoitos o merozoitos de eimeria spp.
DE3177276D1 (de) Monoklonale antikoerper.
ES527730A0 (es) Anticuerpos monoclonales
ES519652A0 (es) Un procedimiento para obtener s-adenosil-metionina.
DE3687487D1 (de) Monoklonaler antikoerper, spezifisch fuer ein pigmentationassoziiertes antigen.
ES554206A0 (es) Un metodo para producir anticuerpos monoclonales
ES511463A0 (es) Un procedimiento para preparar un n-fenil carbamato.
ES518758A0 (es) Un procedimiento para preparar azetidinas.
ES557082A0 (es) Un procedimiento para producir un anticuerpo monoclonal
ES501688A0 (es) Un procedimiento para preparar un aducto fotosensible.
NO894444D0 (no) Anti-fucosylceramid monoklonalt antistoff.
DE3780256D1 (de) Anti-pci-monoklonaler antikoerper.
ES508285A0 (es) Un procedimiento para la determinacion cuantitativa y cualitativa de antigenos, anticuerpos y complejos de los mismos.
ES552781A0 (es) Procedimiento para la obtencion de un anticuerpo monoclonal anti-alfa-amilasa
DE3785795D1 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
NO165945C (no) Anvendelse av monoklonalt fukosebindende antistoff (ggf) for fremstilling av et termisk denaturert glykosidisk bindingsrelatert antigen (gra).
ES523277A0 (es) Un procedimiento para preparar peptidos.
ES524772A0 (es) Un procedimiento para preparar fenilanilinas-n.sustituidas.
NO873488D0 (no) Monoklonale antistoffer.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971201